M1429 – Retinal exam finding with evidence of retinopathy in left, right or both eyes with severity level documented
HCPCS Level II code · M codes: Medical Services and Quality Measures
HCPCS codeM1429
- Long description
- Retinal exam finding with evidence of retinopathy in left, right or both eyes with severity level documented
- Short description
- Retinopathy in od, os, ou
- Pricing indicator
00Not separately priced by Part B (bundled, not covered or Part A only)- Medicare coverage
CCarrier judgment – coverage decided by the Medicare contractor- BETOS category
Z2Undefined codes- Added
- January 1, 2026
- Last change
- January 1, 2026 – No change
Frequently asked questions
What is HCPCS code M1429?
M1429 is a HCPCS Level II code for retinal exam finding with evidence of retinopathy in left, right or both eyes with severity level documented.
Does Medicare cover M1429?
The HCPCS file lists coverage code C: Carrier judgment – coverage decided by the Medicare contractor. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby M codes
- M1421 – Dermatological care mips value pathway
- M1422 – Gastroenterology care mips value pathway
- M1423 – Optimal care for patients with urologic conditions mips value pathway
- M1424 – Pulmonology care mips value pathway
- M1425 – Surgical care mips value pathway
- M1426 – Encounters conducted via telehealth
- M1427 – Documentation of medical reason(s) for performing a bone scan (including documented pain related to prostate cancer, salvage therapy, other medical reasons)
- M1428 – Patients who have bilateral absence of eyes any time during the patient's history through the end of the measurement period
- M1430 – Retinal exam finding without evidence of retinopathy in both eyes with severity level documented (in measurement year or in the prior year)
- M1431 – Encounters conducted via telehealth
- M1432 – Encounters conducted via telehealth
- M1433 – Patient on oral chemotherapy on or within 30 days before denominator eligible encounter
- M1434 – Patient on oral chemotherapy on or within 30 days after denominator eligible encounter
- M1435 – Patient on oral chemotherapy during the performance period
- M1436 – Encounters conducted via telehealth
- M1437 – Encounters conducted via telehealth
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.